The complex machinery required to take a drug through development and regulatory approval can be as arduous as the discovery of the molecule itself. In recent times the demand for COVID-19 drugs has added to the pressure to expedite this process in record time and several organizations working in the small molecule arena have met

The technology-driven world we live in seems to become more complex, more quickly, with every passing day. At a systems level, higher education has responded to the needs of a complex world by promoting specialism, and encouraging deep-dive learning in relatively narrow fields. Specialist expertise is to be valued, but developing the new sustainable processes

Dr John Studley (JS) from Scientific Update spoke to Dr David Barnes (DB) from Abbvie in the US  ahead of our ‘Organic Process Research and Development’ Conference which is taking place in Clearwater, Florida on 9-11 March. We are looking forward to your presentation ‘Discovery of Novel Catalytic Technologies in the Development of Complex Clinical

Dr John Studley, Science Director at Scientific Update and Dr William Goundry from Astra Zeneca got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) We are looking forward to your presentation ‘The Good, the Bad and the Ugly! Successes and Failures from the

Where can DoE fit in process development? Are you using DoE to its full potential? A common misconception with experimental design in chemistry is that its use comes once a process had been planned and tested, just before commercialisation. In fact, DoE is arguably more useful at the start of a process for efficiently screening